Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dull

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Vaccine|July 15, 2017
Combination vaccine strategies to prevent enteric infectionsRichard Walker, Peter Dull
Vaccine|May 15, 2018
HPV single-dose vaccination: Impact potential, evidence base and further evaluationMargaret Stanley, Peter Dull
Vaccine|October 19, 2019
Meeting report: Global vaccine and immunization research forum, 2018Peter Dull, Martin Friede, Angela Hwang, et al.
International Journal of Geriatric Psychiatry|May 16, 2019
Hospital readmission in persons with dementia: A systematic reviewChenjuan Ma, Silin Bao, Peter Dull, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolatesAlan Kimura, Daniela Toneatto, Annett Kleinschmidt, et al.
Vaccine|July 19, 2015
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adultsTerry Nolan, Miguel O'Ryan, James Wassil, et al.
Human Vaccines|February 23, 2011
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescentsChristopher J Gill, Roger Baxter, Alessandra Anemona, et al.
Therapeutic Advances in Vaccines|January 2, 2015
Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionE David McIntosh, Victor Carey, Daniela Toneatto, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Single-dose human papillomavirus vaccination: an updateAimée R Kreimer, Deborah Watson-Jones, Jane J Kim, et al.
Vaccine|April 17, 2012
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlersNicola P Klein, Julie Shepard, Lisa Bedell, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Vaccine|July 15, 2017
Combination vaccine strategies to prevent enteric infectionsRichard Walker, Peter Dull
Vaccine|May 15, 2018
HPV single-dose vaccination: Impact potential, evidence base and further evaluationMargaret Stanley, Peter Dull
Vaccine|October 19, 2019
Meeting report: Global vaccine and immunization research forum, 2018Peter Dull, Martin Friede, Angela Hwang, et al.
International Journal of Geriatric Psychiatry|May 16, 2019
Hospital readmission in persons with dementia: A systematic reviewChenjuan Ma, Silin Bao, Peter Dull, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolatesAlan Kimura, Daniela Toneatto, Annett Kleinschmidt, et al.
Vaccine|July 19, 2015
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adultsTerry Nolan, Miguel O'Ryan, James Wassil, et al.
Human Vaccines|February 23, 2011
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescentsChristopher J Gill, Roger Baxter, Alessandra Anemona, et al.
Therapeutic Advances in Vaccines|January 2, 2015
Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionE David McIntosh, Victor Carey, Daniela Toneatto, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Single-dose human papillomavirus vaccination: an updateAimée R Kreimer, Deborah Watson-Jones, Jane J Kim, et al.
Vaccine|April 17, 2012
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlersNicola P Klein, Julie Shepard, Lisa Bedell, et al.
Pageof 4